Urokinase-type plasminogen activator is required for the generation of a type 1 immune response to pulmonary Cryptococcus neoformans infection

被引:47
|
作者
Gyetko, MR
Sud, S
Chen, GH
Fuller, JA
Chensue, SW
Toews, GB
机构
[1] Ann Arbor Vet Affairs Med Ctr, Pulm & Crit Care Med Div, Dept Internal Med, Ann Arbor, MI 48105 USA
[2] Ann Arbor Vet Affairs Med Ctr, Pulm & Crit Care Med Div, Dept Pathol, Ann Arbor, MI 48105 USA
[3] Univ Michigan, Med Ctr, Ann Arbor, MI 48109 USA
来源
JOURNAL OF IMMUNOLOGY | 2002年 / 168卷 / 02期
关键词
D O I
10.4049/jimmunol.168.2.801
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Urokinase-type plasminogen activator (uPA)(-/-) mice cannot mount protective host defenses during infection with the opportunistic yeast Cryptococcus neoformaus (52D). Because effective host defense against C. neoformans requires specific immune responses and the generation of type 1 (T1) cytokines, we determined how the absence of uPA impacts these processes. Wild-type (WT) and uPA(-/-) mice were inoculated with C. neoformans. Macrophage antifungal activity was assessed histologically, T lymphocyte responses in vivo and proliferation in vitro were quantified, and cytokine concentrations were determined by ELISA. uPA(-/-) macrophages have impaired antimicrobial activity. Regional lymph nodes of infected uPA(-/-) mice contained fewer cells than WT, suggesting impaired T cell proliferation in response to the pathogen in vivo. In vitro, uPA(-/-) T lymphocytes had impaired proliferative responses to C. neoformans rechallenge compared with WT. Infected WT mice generated T1 cytokines in the lung, characterized by high levels of IFN-gamma and IL-12. uPA(-/-) mice had decreased levels of IFN-gamma and IL-12, and increased IL-5, a type 2 cytokine. In the absence of uPA, the cytokine profile of regional lymph nodes shifted from a T1 pattern characterized by IFN-gamma and IL-2 to a weak, nonpolarized response. We conclude that in the absence of uPA, lymphocyte proliferative responses are diminished, and mice fail to generate protective T1 cytokines, resulting in impaired antimicrobial activity. This study provides novel evidence that uPA is a critical modulator of immune responses and of immune cell effector functions in vivo.
引用
收藏
页码:801 / 809
页数:9
相关论文
共 50 条
  • [21] Urokinase-type plasminogen activator and macrophages are required for skeletal muscle hypertrophy in mice
    DiPasquale, Dana M.
    Cheng, Ming
    Billich, William
    Huang, Sharon A.
    van Rooijen, Nico
    Hornberger, Troy A.
    Koh, Timothy J.
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2007, 293 (04): : C1278 - C1285
  • [22] Multiparity upregulates placental plasminogen and urokinase-type plasminogen activator
    Cortina, Maria E.
    Litwin, Silvana
    Hawila, Maria R. Rial
    Miranda, Silvia
    AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2017, 77 (04)
  • [23] Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system
    Yin, SP
    Lockett, J
    Meng, YH
    Biliran, H
    Blouse, GE
    Li, XH
    Reddy, N
    Zhao, ZM
    Lin, XL
    Anagli, J
    Cher, ML
    Sheng, SJ
    CANCER RESEARCH, 2006, 66 (08) : 4173 - 4181
  • [24] Evaluation of plasma urokinase-type plasminogen activator and urokinase-type plasminogen-activator receptor in patients with acute and chronic hepatitis B
    Zhou, Huanqin
    Wu, Xianguo
    Lu, Xingguo
    Chen, Gang
    Ye, Xiongwei
    Huang, Jian
    THROMBOSIS RESEARCH, 2009, 123 (03) : 537 - 542
  • [25] There is no covalent interaction between plasminogen activator inhibitor-1 with urokinase-type plasminogen activator
    Wang, Q
    Shaltiel, S
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 513A - 513A
  • [26] Structural Basis for Recognition of Urokinase-type Plasminogen Activator by Plasminogen Activator Inhibitor-1
    Lin, Zhonghui
    Jiang, Longguang
    Yuan, Cai
    Jensen, Jan K.
    Zhang, Xu
    Luo, Zhipu
    Furie, Barbara C.
    Furie, Bruce
    Andreasen, Peter A.
    Huang, Mingdong
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (09) : 7027 - 7032
  • [27] Urokinase-type plasminogen activator receptor: A beacon of malignancy?
    Drapkin, Ronny
    Clauss, Adam
    Skates, Steven
    CLINICAL CANCER RESEARCH, 2008, 14 (18) : 5643 - 5645
  • [28] Small molecule inhibitors of urokinase-type plasminogen activator
    Rockway, TW
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (06) : 773 - 786
  • [29] Structure, function and antagonists of urokinase-type plasminogen activator
    Carriero, Maria Vincenza
    Franco, Paola
    Vocca, Imma
    Alfano, Daniela
    Votta, Giuseppina
    Longanesi-Cattani, Immacolata
    Bifulco, Katia
    Mancini, Alessandro
    Caputi, Mario
    Stoppelli, Maria Patrizia
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2009, 14 : 3782 - 3794
  • [30] Urokinase-type plasminogen activator receptor in IgA nephropathy
    Ahn, Shin-Young
    Chin, Ho Jun
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2014, 29 (02): : 166 - 169